ANGPTL8 and metabolic dysfunction-associated steatohepatitis: (38) reported significantly lower circulating ANGPTL8 levels in NASH patients compared to NAFLD patients without NASH, while the latter group had significantly higher ANGPTL8 levels than the controls.